FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1084-1085 April 4, 2002 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Woods, W. G. Related Article by Schilling, F. H. PubMed Citation

A major accomplishment of the public health system has been the development of programs of screening newborns for inherited and congenital metabolic disorders. This effort began in response to the observation that severe mental retardation associated with phenylketonuria could be prevented by the early initiation of a diet low in phenylalanine in affected newborns.¹ As a result, universal systems of care were put into place for screening and tracking newborns. When evidence supported benefits from the early detection of and intervention for other disorders, screening tests for these disorders were readily added to the existing systems, resulting in broad access . . . [Full Text of this Article]

References

Related Letters:

Neuroblastoma Screening in Early Life
Suita S., Kerbl R., Urban C. E., Ambros P. F., Collins M. H., Green N. S., Woods W. G., Bernstein M., Robison L. L., Schilling F. H., Spix C., Berthold F.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:852-854, Sep 12, 2002. Correspondence

This article has been cited by other articles:

• Johnson, K., Lloyd-Puryear, M. A., Mann, M. Y., Ramos, L. R., Therrell, B. L. (2006). Financing State Newborn Screening Programs: Sources and Uses of Funds. Pediatrics 117: S270-S279 [Abstract] [Full Text]  
• Grosse, S. D., Boyle, C. A., Kenneson, A., Khoury, M. J., Wilfond, B. S. (2006). From Public Health Emergency to Public Health Service: The Implications of Evolving Criteria for Newborn Screening Panels. Pediatrics 117: 923-929 [Full Text]  
• Boyle, C. A., Cordero, J. F. (2005). Birth Defects and Disabilities: A Public Health Issue for the 21st Century. AJPH 95: 1884-1886 [Full Text]  
• Bailey, D. B. Jr, Skinner, D., Warren, S. F. (2005). Newborn Screening for Developmental Disabilities: Reframing Presumptive Benefit. AJPH 95: 1889-1893 [Abstract] [Full Text]  
• Springer, S. C. (2004). Expanded Newborn Screening Tests: Do the Benefits Exceed the Risks?. AAP Grand Rounds 11: 14-15 [Full Text]  
• Waisbren, S. E., Albers, S., Amato, S., Ampola, M., Brewster, T. G., Demmer, L., Eaton, R. B., Greenstein, R., Korson, M., Larson, C., Marsden, D., Msall, M., Naylor, E. W., Pueschel, S., Seashore, M., Shih, V. E., Levy, H. L. (2003). Effect of Expanded Newborn Screening for Biochemical Genetic Disorders on Child Outcomes and Parental Stress. JAMA 290: 2564-2572 [Abstract] [Full Text]  
• Suita, S., Kerbl, R., Urban, C. E., Ambros, P. F., Collins, M. H., Green, N. S., Woods, W. G., Bernstein, M., Robison, L. L., Schilling, F. H., Spix, C., Berthold, F. (2002). Neuroblastoma Screening in Early Life. NEJM 347: 852-854 [Full Text]  
• Perry, R., Heinrichs, C., Bourdoux, P., Khoury, K., Szots, F., Dussault, J. H., Vassart, G., Van Vliet, G. (2002). Discordance of Monozygotic Twins for Thyroid Dysgenesis: Implications for Screening and for Molecular Pathophysiology. J. Clin. Endocrinol. Metab. 87: 4072-4077 [Abstract] [Full Text]  
• (2002). Screening for Neuroblastoma: Not Yet. JWatch Pediatrics 2002: 2-2 [Full Text]  
• (2002). Screening for Neuroblastoma: Not Yet. JWatch General 2002: 7-7 [Full Text]